| Serial Number | 98313178 |
| Word Mark | SNAPLVV |
| Filing Date | Wednesday, December 13, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, February 17, 2026 |
| Registration Number | 8146203 |
| Registration Date | Tuesday, February 17, 2026 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 15, 2024 |
| Goods and Services | Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; biomanufacturing for others, namely, platforms for manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology |
| Goods and Services | Research, development, and consulting services related thereto in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; genetic engineering services, namely, research in the field of genetics; biotechnology research and development; scientific, pharmaceutical, and medical research services in the field of biological treatment and bioproduction; design and development of biotechnology platforms relating to biological treatment for use in the manufacture of pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; providing scientific research information, namely, provision of information for research and development of biopharmaceuticals that are manufactured using biological treatment and bioproduction platforms; development of new technology for others in the field of biotechnology, biomanufacturing, and pharmaceuticals; new product design services; biotechnology design services, namely, the creation of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 13, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | Wednesday, January 31, 2024 |
| First Use In Commerce Date | Wednesday, January 31, 2024 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 13, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, January 31, 2024 |
| First Use In Commerce Date | Wednesday, January 31, 2024 |
| Party Name | National Resilience, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | National Resilience, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | National Resilience, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Event Date | Event Description |
| Wednesday, December 13, 2023 | NEW APPLICATION ENTERED |
| Monday, March 18, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 12, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, July 16, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 16, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 16, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, August 30, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, August 30, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 30, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, September 7, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 25, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 15, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 15, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 26, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, May 12, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, October 14, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, May 12, 2025 | USE AMENDMENT FILED |
| Tuesday, October 14, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, January 26, 2026 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Monday, January 26, 2026 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Wednesday, February 11, 2026 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Wednesday, February 11, 2026 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, February 11, 2026 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, February 11, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, February 11, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, February 11, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 11, 2026 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Tuesday, February 17, 2026 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 17, 2026 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |